Not Tagged
Not Tagged
['mibc']
surv outcomes in pts w/ mibc receiving nac stratified by # of cycles n=195; 30 (15.3%) &lt; 3 cycles, 165 (84.6%) 3 cycles nac ypt0n0: 7.4% &lt; 3 cycles, 26.8% 3 cycles nac (p=0.024) &lt; ypt2: 22.2% &lt; 3 cycles, 41.8% 3 cycles nac (p=0.05) #asco23 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor